Keyword: Johnson & Johnson

News

J&J Clinches $1 Billion US Vaccine Supply Deal

06.08.2020 -

Johnson & Johnson (J&J) has struck a deal with the US government worth just over $1 billion to supply 100 million doses of subsidiary Janssen’s SARS-CoV-2 investigational...

News

EU’s Covid-19 Vaccine Talks Said to Hit Snag

29.07.2020 -

European officials recently began talking to companies developing Covid-19 vaccines about supplying the EU’s 27 member states, in hope that none would fall behind bigger...

News

BASF, US Law Firm Settle Engelhard Talc Cases

28.07.2020 -

Through an acquisition dating back 14 years, BASF is embroiled in the same type of litigation trap as compatriot Bayer currently faces. The Ludwigshafen group’s US...

News

UK Won’t Join EU Vaccine Purchase Plan

14.07.2020 -

The UK will not participate in a plan to distribute a potential coronavirus vaccine to Europe’s most vulnerable citizens first. Tim Barrow, the UK’s ambassador to the EU...

News

J&J to Pull Talc Baby Powder from North America

21.05.2020 - As lawsuits against Johnson & Johnson (J&J) claiming its iconic baby powder causes cancer continue to mount, the US healthcare giant has announced plans to pull the talc-based...

Strategy & Management

Continuous Pharmaceutical Manufacturing

15.04.2020 - The pharmaceutical industry has been slowly, but surely, embrac­ing continuous manufacturing (CM) over the past decade. In fact, most large pharma companies have invested in...

News

New Study Relativizes Talc-Cancer Ties

13.01.2020 - A new study published in the Journal of the American Medical Association (JAMA), which found “no statistically significant association” between genital talc use and ovarian cancer...

News

J&J Wins one Lawsuit, New Cases Loom

06.01.2020 - US healthcare giant Johnson & Johnson has been on a roller coaster ride for around two years, and its fortunes – along with its share price – continued moving up and down as 2019...